Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4851820 | 0.83 | OPRM1 (0.41) | — | |
| SCHEMBL15436603 | 0.83 | TDP1 (0.40) | CHRM2HTR2AHRH1TDP1 | |
| SCHEMBL5581501 | 0.83 | ENPEP (0.36) | — | |
| SCHEMBL8851759 | 0.82 | CHRM2 (0.33) | CHRM2TDP1 | |
| SCHEMBL16163286 | 0.81 | DNM1 (0.44) | — | |
| Hydrochloric Acid SCHEMBL28652633 | 0.81 | TDP1 (0.30) | CHRM2TDP1 | |
| SCHEMBL16163245 | 0.81 | DNM1 (0.44) | — | |
| SCHEMBL16163198 | 0.81 | DNM1 (0.44) | — | |
| SCHEMBL16163299 | 0.81 | DNM1 (0.44) | — | |
| SCHEMBL16163223 | 0.81 | DNM1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119264155-A | Latent curing agent based on dynamic crosslinking-controllable dissolution mechanism | 江南大学 | 2025-01-07 | — | — | CN | disclosed |
| EP-2655488-B1 | COMPOSITIONS COMPRISING QUAT COMPOUNDS AND ORGANOPOLYSILOXANES | WACKER CHEMIE AG (DE) | 2014-12-03 | — | — | EP | disclosed |
| CN-103080071-B | Beta-ketocarbonylquat compounds and process for the preparation thereof | WACKER CHEMIE AG | 2014-12-03 | — | — | CN | disclosed |
| EP-2794705-A1 | FLUOROCHEMICAL COMPOSITION AND USE THEREOF | Clariant International Ltd. (CH) | 2014-10-29 | — | — | EP | disclosed |
| EP-2601171-B1 | BETA-KETOCARBONYLQUAT COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | WACKER CHEMIE AG (DE) | 2014-09-03 | — | — | EP | disclosed |
| US-8722612-B2 | Compositions comprising quat compounds and organopolysiloxanes | WACKER CHEMIE AG (DE) | 2014-05-13 | — | — | US | disclosed |
| US-8722926-B2 | Beta-ketocarbonylquat compounds and process for the preparation thereof | WACKER CHEMIE AG (DE) | 2014-05-13 | — | — | US | disclosed |
| US-20130296220-A1 | COMPOSITIONS COMPRISING QUAT COMPOUNDS AND ORGANOPOLYSILOXANES | WACKER CHEMIE AG (DE) | 2013-11-07 | — | — | US | disclosed |
| EP-2655488-A1 | COMPOSITIONS COMPRISING QUAT COMPOUNDS AND ORGANOPOLYSILOXANES | Wacker Chemie AG (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2013091804-A1 | FLUOROCHEMICAL COMPOSITION AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2013-06-27 | — | — | WO | disclosed |
| EP-2601171-A1 | BETA-KETOCARBONYLQUAT COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | Wacker Chemie AG (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20130123535-A1 | Beta-Ketocarbonylquat Compounds and Process for the Preparation thereof | WACKER CHEMIE AG (DE) | 2013-05-16 | — | — | US | disclosed |
| CN-103080071-A | Beta-ketocarbonylquat compounds and process for the preparation thereof | WACKER CHEMIE AG | 2013-05-01 | — | — | CN | disclosed |
| WO-2012084830-A1 | COMPOSITIONS COMPRISING QUAT COMPOUNDS AND ORGANOPOLYSILOXANES | WACKER CHEMIE AG (DE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012016837-A1 | BETA-KETOCARBONYLQUAT COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | WACKER CHEMIE AG (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-5076900-A | Aminoplast containing cathodic electrodeposition baths | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-12-31 | — | — | US | disclosed |
| US-4608300-A | STORAGE STABILITY, AMINE CURING AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-08-26 | — | — | US | disclosed |
| EP-0133154-A1 | Composites impregnated with a hardenable epoxy resin matrix | CIBA-GEIGY AG (CH) | 1985-02-13 | — | — | EP | disclosed |
| US-4118439-A | IONICALLY CROSSLINKED QUATERNARY AMMONIUM POLYMER | RHONE-POULENC S.A. (FR) | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123535-A1 | Beta-Ketocarbonylquat Compounds and Process for the Preparation thereof | KCNAB1, KCNH3, KCNH2 | CHRM2 2527/4885NFKB1 850/4885HTR2A 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.